Mostrar el registro sencillo del ítem
Efficacy and safety of paliperidone palmitate 6-month versus paliperidone palmitate 3-month long-acting injectable in european patients with schizophrenia: a post hoc analysis of a global phase-3 double-blind randomized non-inferiority study
dc.contributor.author | Girón Hernández, César | |
dc.contributor.author | Han, Joong Hee | |
dc.contributor.author | Alberio, Roberta | |
dc.contributor.author | Singh, Arun | |
dc.contributor.author | García-Portilla González, María Paz | |
dc.contributor.author | Pompili, Maurizio | |
dc.contributor.author | Knight, R. Karl | |
dc.contributor.author | Richarz, Ute | |
dc.contributor.author | Gopal, Srihari | |
dc.contributor.author | Antunes, José | |
dc.date.accessioned | 2023-11-07T09:58:13Z | |
dc.date.available | 2023-11-07T09:58:13Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Neuropsychiatric Disease and Treatment, 19, p. 895-906 (2023); doi:10.2147/NDT.S400342 | |
dc.identifier.uri | https://hdl.handle.net/10651/70072 | |
dc.format.extent | p. 895-906 | |
dc.language.iso | eng | |
dc.relation.ispartof | Neuropsychiatric Disease and Treatment | |
dc.rights | © 2023 The author(s). This work is published and licensed by Dove Medical Press Ltd | |
dc.rights | CC Reconocimiento - No Comercial 3.0 | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/ | |
dc.source | WOS:000970784500001 | |
dc.title | Efficacy and safety of paliperidone palmitate 6-month versus paliperidone palmitate 3-month long-acting injectable in european patients with schizophrenia: a post hoc analysis of a global phase-3 double-blind randomized non-inferiority study | |
dc.type | journal article | |
dc.identifier.doi | 10.2147/NDT.S400342 | |
dc.relation.publisherversion | http://dx.doi.org/10.2147/NDT.S400342 | |
dc.rights.accessRights | open access | |
dc.type.hasVersion | VoR |
Ficheros en el ítem
